-
REAL-WORLD COST-UTILITY EVIDENCE SUPPORTING ORAL HEALTH INTEGRATION IN DIABETES CARE IN CHILE
Aug 11, 2026, 15:45 PM -
AI-SUPPORTED PRE-MORTEM ANALYSIS FOR HEOR STRATEGIES: LESSONS FROM PROJECT MANAGEMENT SCIENCE OBJECTIVES
Aug 11, 2026, 15:45 PM -
ANTIMICROBIAL STEWARDSHIP POLICY IMPLEMENTATION DURING COVID-19 PANDEMIC: A NATIONWIDE SERIAL CROSS-SECTIONAL STUDY
Aug 11, 2026, 15:45 PM -
CLINICAL COST-EFFECTIVENESS ANALYSIS OF NAAT DIAGNOSTICS FOR ACTIVE TB DIAGNOSIS AND RIFAMPICIN RESISTANCE TESTING IN PUBLIC PRIMARY HEALTHCARE IN INDIA
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS OF HIGH-DOSE INFLUENZA VACCINE STRATEGIES FOR OLDER ADULTS IN JAPAN
Aug 11, 2026, 15:45 PM -
CLINICAL BURDEN AND HEALTH-RELATED QUALITY OF LIFE IN CERVICAL CANCER ACROSS FIVE HIGH-BURDEN ASIA-PACIFIC COUNTRIES: A TARGETED LITERATURE REVIEW...
Aug 11, 2026, 15:45 PM -
EVOLVING USE AND ACCEPTANCE OF REAL-WORLD EVIDENCE WITHIN HTA IN JAPAN BY MANUFACTURERS AND THE ATAG: INSIGHTS FROM C2H REPORTS
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB AS FIRST-LINE TREATMENT FOR NON-SMALL CELL LUNG CANCER IN JAPAN
Aug 11, 2026, 15:45 PM -
HEALTH-RELATED QUALITY OF LIFE TRAJECTORIES AFTER ACUTE STROKE: A 90-DAY PROSPECTIVE LONGITUDINAL COHORT STUDY
Aug 11, 2026, 15:45 PM -
COST-EFFECTIVENESS OF COLORECTAL CANCER SCREENING STRATEGIES IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Aug 11, 2026, 15:45 PM -
ACCELERATING ONCOLOGY EVIDENCE SYNTHESIS: A MULTI-LLM FRAMEWORK FOR AUTOMATED SYSTEMATIC LITERATURE REVIEW SCREENING...
Aug 11, 2026, 15:45 PM -
DELAYING INTRACRANIAL PROGRESSION IN NSCLC BRAIN METASTASES: CLINICAL AND PATIENT-CENTERED VALUE...
Aug 11, 2026, 15:45 PM -
THE COST-EFFECTIVENESS OF USING PIVKA-II IN COMBINATION WITH ULTRASOUND-AFP IN DETECTING HEPATOCELLULAR CARCINOMA
Aug 11, 2026, 15:45 PM -
LARGE LANGUAGE MODEL-EXTRACTED CLINICAL FEATURES ENHANCED STRUCTURED ELECTRONIC MEDICAL RECORDS DATA FOR PREDICTING TREATMENT RESPONSE DEPTH IN MULTIPLE MYELOMA
Aug 11, 2026, 15:45 PM -
CROSS-AGENCY APPRAISAL OF REAL-WORLD EVIDENCE IN ONCOLOGY AND RARE DISEASE DRUG-INDICATION HTA APPRAISALS ACROSS SELECT APAC MARKETS AND ENGLAND: A COMPARATIVE HTA APPRAISAL REVIEW (2021-2026)
Aug 11, 2026, 15:45 PM -
ARTIFICIAL INTELLIGENCE APPLICATIONS IN HEALTH TECHNOLOGY ASSESSMENT ACROSS ASIA-PACIFIC: A TARGETED REVIEW OF USE CASES, ADOPTION BARRIERS, AND OPPORTUNITIES
Aug 11, 2026, 15:45 PM -
IS THE U.S. MOST FAVORED NATION (MFN) INITIATIVE EXPECTED TO AFFECT DRUG LAUNCHES IN KOREA...
Aug 11, 2026, 15:45 PM -
PERSISTENT DEPRESSION ON PRESENTEEISM AND PRODUCTIVITY LOSS IN CHINESE ADULTS WITH YOUNG-ONSET TYPE 2 DIABETES IN HONG KONG: A LONGITUDINAL ANALYSIS FROM THE PRISM-RCT
Aug 11, 2026, 15:45 PM -
EXPLORING BARRIERS TO TIMELY BREAST CANCER CARE: IMPLICATIONS FOR AFFORDABLE AND PATIENT - CENTERED HEALTH SYSTEMS
Aug 11, 2026, 15:45 PM -
PATIENT VOICE BEYOND HTA: A CASE-BASED REVIEW OF INFORMAL MECHANISMS SHAPING ACCESS IN 15 GLOBAL JURISDICTIONS
Aug 11, 2026, 15:45 PM
